Invitation to the new MDDS Programme:

Master of Advanced Studies (MAS) in Drug Development Sciences

We are pleased to introduce the new MDDS Programme on the ECPM Training Platform covering the entire Drug Development Process. This programme extends the European Course in Pharmaceutical Medicine which provides the basic knowledge of the entire value chain from molecule to marketplace.

To cope with the challenges of drug development, training and skills are needed to critically assess and improve the drug development process by efficiently using the health care resources are needed. We are offering this postgraduate Master Programme in Drug Development Sciences to fill this gap. The programme is designed and organised by ECPM (European Center of Pharmaceutical Medicine) together with different health care partner organisations.

The MDDS programme will be part of the IMI (Innovative Medicines Initiative, a joint undertaking between the EU, Academia and EFPIA) training initiative. Please see more details in www.pharmatrain.org.

Target Audience

 

MDDS is targeted for the industry, service industry, academic and government of decision- and policy-makers who have a good grounding in the basic understanding of drug development and will benefit from a more in-depth, comprehensive and systematic immersion into modern medical product development, regulation and market introduction.

Eligibility Criteria

 

To be eligible for enrolment in the MDDS programme, applicants must have a higher university degree, such as Master in Life Sciences, MD or PhD and a primary interest in medical product discovery, development, regulation or related activity.

The programme is particularly aimed at professionals who are involved in the medical product development process and have at least 2 years of working experience.